<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Musculoskelet Disord</journal-id><journal-title-group><journal-title>BMC Musculoskeletal Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27278385</article-id><article-id pub-id-type="pmc">4899888</article-id><article-id pub-id-type="publisher-id">1109</article-id><article-id pub-id-type="doi">10.1186/s12891-016-1109-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Gombos</surname><given-names>Gabriella Cs&#x000e1;sz&#x000e1;rn&#x000e9;</given-names></name><address><email>gabriella.gombos@etk.pte.hu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Bajsz</surname><given-names>Vikt&#x000f3;ria</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;k</surname><given-names>Emese</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>B&#x000e9;la</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Si&#x000f3;</surname><given-names>Eszter</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Molics</surname><given-names>B&#x000e1;lint</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Betlehem</surname><given-names>J&#x000f3;zsef</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">University of P&#x000e9;cs, Faculty of Health Sciences, 33 Landorhegyi Road, Zalaegerszeg, 8900 Hungary </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>17</volume><elocation-id>254</elocation-id><history><date date-type="received"><day>20</day><month>5</month><year>2015</year></date><date date-type="accepted"><day>1</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Csaszarne Gombos et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Both gravitational loading and the forces generated by muscle contraction have direct effects on serum markers of bone metabolism. The object of this study was to examine the direct effects of a single session of resistance exercise or walking on biochemical markers of bone metabolism in participants with low bone mass.</p></sec><sec><title>Methods</title><p>A total of 150 otherwise healthy female subjects (mean age&#x02009;=&#x02009;59.1&#x02009;&#x000b1;&#x02009;7.1&#x000a0;years) diagnosed with osteoporosis or osteopenia were randomly allocated to either a resistance exercise group (RG; <italic>n</italic>&#x02009;=&#x02009;50), walking group (WG; <italic>n</italic>&#x02009;=&#x02009;50), or control group (CG; <italic>n</italic>&#x02009;=&#x02009;50). Changes in bone-specific alkaline phosphatase (BALP), carboxy-terminal cross-linked telopeptide of type I collagen (CTX), and serum sclerostin concentrations were measured before and immediately after a single exercise intervention.</p></sec><sec><title>Results</title><p>There was no significant change in BALP values in any of the groups. Sclerostin levels increased in the RG and WG, and there was significant difference between the WG and CG after the exercise intervention (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). In contrast, the changes in CTX concentrations from baseline were significant in the RG (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) but not in the WG (<italic>P</italic>&#x02009;=&#x02009;0.11), and there was a significant difference between resistance exercise and walking (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></sec><sec><title>Conclusions</title><p>In participants with low bone mass, resistance exercise influenced the serum concentrations of CTX, a marker of bone resorption, but walking did not.</p></sec><sec><title>Trial registration</title><p>Current Controlled Trials <ext-link ext-link-type="uri" xlink:href="http://www.isrctn.com/ISRCTN16329455">ISRCTN16329455</ext-link>; retrospectively registered on 05/05/2016.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Low bone mass</kwd><kwd>Exercise</kwd><kwd>Walking</kwd><kwd>BALP</kwd><kwd>CTX</kwd><kwd>Sclerostin</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Biochemical markers of bone metabolism that reflect the cellular activity related to the formation and resorption of bone are useful in monitoring physical activity, and can help us understand the effects of exercise on bone [<xref ref-type="bibr" rid="CR1">1</xref>]. The specific mechanisms by which physical exercise exerts its effects on bone metabolism have not yet been fully elucidated. &#x0201c;Bone quality&#x0201d; can be determined by several parameters, including the extent of mineralization, the number and distribution of microfractures, the rate of osteocyte apoptosis, and changes in the collagenous bone matrix [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>The anabolic effect of physical exercise on osseous tissue is related to mechanical effort, although the osteogenic response may also be influenced by other factors [<xref ref-type="bibr" rid="CR3">3</xref>]. Physical loads associated with exercise impact bone mass and structure by causing dynamic changes to local mechanical conditions, which stimulate resident osteocytes through fluid shifts in their canalicular network. These osteocytes then produce signaling molecules that regulate bone formation and absorption by osteoblast and osteoclasts [<xref ref-type="bibr" rid="CR4">4</xref>]. Bone tissue has an intrinsic &#x0201c;mechanostat&#x0201d; that regulates functional adaptation to stresses [<xref ref-type="bibr" rid="CR5">5</xref>]. Bone deformation of 1500&#x02013;3000 &#x003bc;&#x003b5; (physiological overload) induces modeling of the bone cortex, while that of 100&#x02013;300 &#x003bc;&#x003b5; induces bone multicellular unit (BMU) remodeling. Strain below 100 &#x003bc;&#x003b5; is associated with bone loss (disuse atrophy), and fractures may occur with pathological overload [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>Bone metabolism is influenced by several local factors including the receptor activator of nuclear factor &#x00138; B (RANK) ligand (RANKL) and osteoprotegerin (OPG) cytokine system, inflammatory cytokines, growth factors, bone morphogenetic proteins, transforming growth factor, prostaglandins, colony stimulating factors, and interleukins [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. RANKL, a product of osteoblasts, lymphocytes, and bone marrow cells, is the most powerful stimulator of osteoclastogenesis [<xref ref-type="bibr" rid="CR6">6</xref>]. It exerts its activity by binding to RANK on the cell surface of osteoclast progenitor cells and stimulating their differentiation to mature osteoclasts. OPG blocks the binding of RANKL to RANK and regulates bone resorption by inhibiting osteoclast differentiation [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p>Bone mass can be measured well by densitometry; however, it is more difficult to accurately examine bone structure and strength in live tissue. Some substances produced during bone remodeling are specific biochemical markers of bone metabolism. Products of active osteoblasts can serve as markers of bone formation; serum concentrations of these markers reflect osteoblast function during specific phases of bone formation [<xref ref-type="bibr" rid="CR9">9</xref>]. Alkaline phosphatase is a ubiquitous tetramer enzyme bound to the cell membrane [<xref ref-type="bibr" rid="CR9">9</xref>]. In bone, bone-specific alkaline phosphatase (BALP) is present on the surface of osteoblasts and plays an important role in osteoid production and mineralization [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Cross-linked telopeptides of type I collagen include C-terminal (CTX, carboxy-terminal cross-linked telopeptide) and N-terminal (NTX, amino-terminal cross-linked telopeptide). These fragments can be produced via different collagen degradation pathways. CTX and NTX are released during the cleavage of cathepsin K [<xref ref-type="bibr" rid="CR12">12</xref>]. Several assays are available that examine the structural variations in peptide sequences in the CTX [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and CTX is one of the most sensitive and specific markers of osteoclast-mediated collagen degradation [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition to osteoblasts and osteoclasts, osteocytes also play an important role in the process of bone remodeling, mainly in its terminal stage, through the production of regulatory factors such as sclerostin (sclerostin gene: SOST). Sclerostin acts on bone surface osteoblasts to inhibit their activity and promote apoptosis [<xref ref-type="bibr" rid="CR16">16</xref>]. During normal physiological states, the protein sclerostin is differentially expressed in response to mechanical loading, inflammatory molecules such as prostaglandin E2, and hormones such as parathyroid hormone and estrogen [<xref ref-type="bibr" rid="CR17">17</xref>]. Relatively few studies have researched the effects of physical training on sclerostin levels. Serum concentrations of sclerostin have been shown to be increased by immobilization [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], decreased by physical activity in premenopausal women [<xref ref-type="bibr" rid="CR20">20</xref>], and to remain steady in physically active postmenopausal women [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p>Weight-bearing and resistance exercises that improve muscle strength are essential for preserving the health of the musculoskeletal system [<xref ref-type="bibr" rid="CR22">22</xref>]. Coordination, self-assurance, and appropriate muscular strength help to prevent falls and preserve bone mass by stimulating bone formation and reducing bone resorption [<xref ref-type="bibr" rid="CR23">23</xref>]. Training programs aimed at preserving bone health should incorporate three basic components: 1) impact exercise, such as brisk walking or jogging; 2) strength training with weights; and 3) balance training [<xref ref-type="bibr" rid="CR24">24</xref>], while lower-impact exercises, such as walking, have minimal effects on density [<xref ref-type="bibr" rid="CR25">25</xref>]. In contrast to aerobic exercise training, resistance training may have more profound site-specific effects on bone, and progressive resistance training has further advantages in patients with osteoporosis (OP) due to the resulting improvements in muscle strength, mass, and balance [<xref ref-type="bibr" rid="CR26">26</xref>]. The purpose of this study was to describe the acute response of plasma markers of bone formation (BALP) and resorption (CTX and sclerostin) to a single session of either walking or resistance exercise.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Participants</title><p>A total of 150 female subjects diagnosed with osteoporosis/osteopenia (mean age: 58.5&#x02009;&#x000b1;&#x02009;7.5&#x000a0;years) were included in this study. Untreated subjects with recently diagnosed osteoporosis/osteopenia were recruited through a large-scale screening program promoted by the Department of Rheumatology at the Zala County Hospital, Hungary, and implemented through a network of family doctors. The needed sample size was calculated based on expected effect size and study power. There are previous studies in similar contexts with similar interventions which enable exact estimations (<italic>d</italic>&#x02009;=&#x02009;0.3) [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Thus, setting alpha risk to 0.05 and power to 0.08, a sample of 50 per group was needed for two-tailed tests. Nearly 1400 women were examined; 712 were diagnosed as having osteoporosis/osteopenia and 65 of these were excluded because of other health conditions. Thereafter, the women were contacted in random order until 150 had agreed to participate in our study. The participants were randomly assigned to a resistance exercise group (RG; <italic>n</italic>&#x02009;=&#x02009;50), walking group (WG; <italic>n</italic>&#x02009;=&#x02009;50), or control group (CG; <italic>n</italic>&#x02009;=&#x02009;50). Exclusion criteria included (1) any condition influencing calcium and bone metabolism (except dietary calcium and Vitamin D supplementation), (2) ongoing hormone replacement therapy, (3) any known endocrine/metabolic, renal, or hepatic disease (e.g., hypogonadism, hyperthyroidism, hyperparathyroidism, or increased glucocorticoid levels), (4) any physical injury (orthopedic, rheumatologic) hindering the performance of physical activity, (5) osseous fracture of any origin during the previous 6&#x000a0;months, (6) a diagnosis of cardiovascular disease or uncontrolled hypertension, (7) any non-antibiotic medication within the past year, including steroids of any type, thyroid hormones, diuretics, or anticoagulants, and (8) any antibiotic use within the last 6&#x000a0;months.</p><p>Ethical approval for this study was issued by the Regional Committee of Science and Research Ethics and the Policy Administration Service of Public Health of Zala County. All participants received written and verbal information regarding the purpose and procedures of the study, and all gave their written informed consent before participation. After the study, appropriate antiporotic medication was provided to the participants as required.</p></sec><sec id="Sec4"><title>Study design</title><sec id="Sec5"><title>Resistance exercise group (RG)</title><p>The mean age of the participants in the RG was 60.2&#x02009;&#x000b1;&#x02009;6.9&#x000a0;years. Their exercise session included 8&#x000a0;min of dynamic warm-up consisting of exercises requiring movements of large muscle groups and major joints that incorporated small impacts with the ground (steps, combinations of steps, hopping, stretching) [<xref ref-type="bibr" rid="CR24">24</xref>]. The main part of the session comprised approximately 30&#x000a0;min of exercises that included muscle-strengthening and core stabilization elements. A list of the exercises is provided in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. All exercises were performed as a continuous set; this was followed by a 2-min rest period between sets, and three sets were performed. At the end of the session an 8&#x000a0;min cool down consisting of walking and static and dynamic stretches was performed [<xref ref-type="bibr" rid="CR24">24</xref>]. The participants familiarized themselves with the exercises prior to participating in the study session.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Exercises performed by the resistance exercise group during the main part of their exercise session</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Starting position</th><th>Description of the exercise</th><th>Number of repetitions in 1 set</th></tr></thead><tbody><tr><td>Lying supine with feet on the ground 10&#x000a0;cm apart, arms at sides with palms down.</td><td>Shoulder bridge &#x02013; The pelvis is slowly lifted with tense abdominal and gluteal muscles. This position is held and the knees are alternately extended. The pelvis is then slowly lowered.</td><td>4&#x000d7;/side</td></tr><tr><td>Lying supine with the hips and knees flexed at 90&#x000b0;</td><td>One leg with flexed knee is lowered towards the ground while the contralateral arm is raised vertically. This position is held 2&#x000a0;s and then the exercise is repeated with the opposite limbs.</td><td>4&#x000d7;/side</td></tr><tr><td>Kneeling position, elbows and forearms on the floor, knees under the hips, trunk stabilized, spine and pelvis stable.</td><td>Swimming - The contralateral arm and leg are simultaneously raised until level with the trunk. The exercise is then repeated with the opposite limbs.</td><td>4&#x000d7;/side</td></tr><tr><td>Static forearm plank.</td><td>One leg is raised with the knee extended (lumbar spine in neutral), the position is held for 2&#x000a0;s and then the leg is slowly lowered. This is then repeated with the opposite leg.</td><td>4&#x000d7;/side</td></tr><tr><td>Static low forearm plank.</td><td>The pelvis in held in a raised position for 2&#x000a0;s and then lowered.</td><td>6x/side</td></tr><tr><td>Sitting on a physioball, legs apart, soles on the ground, hands holding a green band.</td><td>The participant leans forward from the hip to 45&#x000b0; with shoulders at approximately 150&#x000b0; flexion while stretching the band. This position is held for 2&#x000a0;s and then the participant slowly returns to the starting position.</td><td>8x</td></tr><tr><td>Standing straight with feet hip width apart and a ball between the back and a wall.</td><td>Ball squatting against a wall &#x02013; The participant leans into the ball and squats until the thighs are parallel to the ground. The arms are raised and this position is held for 2&#x000a0;s.</td><td>8x</td></tr><tr><td>Standing with feet hip width apart and tense trunk muscles.</td><td>Backward lunge &#x02013; The knees are bent to a lunge position, which is held for 2&#x000a0;s before returning to the starting stance.</td><td>4&#x000d7;/side</td></tr><tr><td>Standing with 1&#x000a0;kg weights in both hands.</td><td>The participant performs a forward lunge while abducting the arms to 90&#x000b0; and then returns to the starting position.</td><td>4&#x000d7;/side</td></tr><tr><td>Standing with feet hip width apart and arms straight in front.</td><td>The participant steps right/left and lowers into a side lunge before returning to the starting position.</td><td>4&#x000d7;/side</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec6"><title>Walking group (WG)</title><p>The mean age of participants in the WG was 58.7&#x02009;&#x000b1;&#x02009;6.3&#x000a0;years. Their exercise session consisted of moderate intensity brisk walking (approximately 3&#x02013;6 metabolic equivalents) to a rhythm (100 steps/min) provided by a metronome. In this rhythm, they walked continuously for 46&#x000a0;min outdoors on even ground (wearing training shoes). The subjects familiarized themselves with the walking style prior to participating in the study session.</p></sec><sec id="Sec7"><title>Control group (CG)</title><p>The mean age of participants in the control group was 57.8&#x02009;&#x000b1;&#x02009;8.4&#x000a0;years. These women did not receive any intervention.</p></sec></sec><sec id="Sec8"><title>Laboratory tests</title><p>Serum samples were collected and concentrations of markers of bone metabolism were measured at baseline and immediately after the interventions. Several assistants performed sample collection simultaneously to ensure rapid collection within 0&#x02013;5&#x000a0;min after the exercise sessions. All baseline blood samples were collected between 8:00 and 8:30&#x000a0;AM to minimize circadian effects. Prior to the interventions the participants refrained from exercising for 24&#x000a0;h and fasted overnight. BALP was measured after lectin precipitation using a photometric assay. Test was performed on an Olympus AU 480 Chemistry Analyzer (Brea, USA). CTX was measured by an electrochemiluminescence immunoassay [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. The reagents for CTX analysis were purchased from Roche (Mannheim, Germany), and measurements were made on a Cobase 411 immunochemical analyzer (Mannheim, Germany). Serum sclerostin (SOST) concentrations were determined by qualitative sandwich enzyme-linked immunosorbent assay (Biomedica, Vienna, Austria). The intra-assay CV was 5&#x02013;6&#x000a0;%, the inter-assay CV was 2&#x02013;6&#x000a0;%.</p></sec><sec id="Sec9"><title>Physiotherapist-conducted interviews</title><p>Participants completed a physiotherapist-administered questionnaire specifically designed to collect demographic data and medical history for this study. Previous and existing diseases (e.g., hypertension, heart disease, bronchial asthma, arthritis, surgical interventions, and autoimmune diseases), medications and supplements (such as Vitamin D), lifestyle factors (sports participation, diet, smoking, and alcohol and coffee consumption), and current physical activity level were determined using the international physical activity questionnaire (IPAQ) [<xref ref-type="bibr" rid="CR31">31</xref>]. The height of the participants was measured on a Seca medical stadiometer (Birmingham, UK) and their weight was checked on an Omron digital scale (Osaka, Japan).</p></sec><sec id="Sec10"><title>Data analysis</title><p>All statistical analyses were performed using SPSS (IBM SPSS, Inc., Version 20.0, 2011). Results are expressed as means and standard deviations. Data were checked for normality of distribution by the Kolmogorov-Smirnov test. Levene&#x02019;s test was used to test homoscedasticity. For the clinical parameters, paired t-tests were used to determine the significance of differences in continuous variables. A two (time) by three (intervention) analysis of variance (ANOVA) with repeated measures was conducted to explore between- and within-group differences and Scheffe post hoc analysis was used to determine the significance of all possible comparisons. The &#x003b1;-level was set at 0.05 for all analyses.</p></sec></sec><sec id="Sec11"><title>Results</title><sec id="Sec12"><title>Participant characteristics</title><p>Participant characteristics are presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. There were no significant baseline differences between the groups. The BMI values of the participants ranged from 14.8 to 39.2, with a mean BMI of 27.0&#x02009;&#x000b1;&#x02009;5.4. The participants&#x02019; T-scores varied between &#x02212;4.7 and &#x02212;1.0 (mean: &#x02212;2.1&#x02009;&#x000b1;&#x02009;0.8); 38 participants had osteoporosis and 112 had osteopenia. T-scores did not significantly differ between the groups (<italic>P</italic>&#x02009;=&#x02009;0.31).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Baseline characteristics of the participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>RG (<italic>n</italic>&#x02009;=&#x02009;50)</th><th>WG (<italic>n</italic>&#x02009;=&#x02009;50)</th><th>CG (<italic>n</italic>&#x02009;=&#x02009;50)</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>Age, years</td><td>60.2&#x02009;&#x000b1;&#x02009;6.9</td><td>58.7&#x02009;&#x000b1;&#x02009;6.3</td><td>57.8&#x02009;&#x000b1;&#x02009;8.4</td><td char="." align="char">0.15</td></tr><tr><td>Height, cm</td><td>162.6&#x02009;&#x000b1;&#x02009;9.8</td><td>159.6&#x02009;&#x000b1;&#x02009;6.4</td><td>161.7&#x02009;&#x000b1;&#x02009;5.0</td><td char="." align="char">0.06</td></tr><tr><td>Weight, kg</td><td>69.7&#x02009;&#x000b1;&#x02009;11.8</td><td>72.7&#x02009;&#x000b1;&#x02009;14.8</td><td>69.5&#x02009;&#x000b1;&#x02009;13.0</td><td char="." align="char">0.41</td></tr><tr><td>BMI, kg/m<sup>2</sup>
</td><td>26.3&#x02009;&#x000b1;&#x02009;5.4</td><td>27.2&#x02009;&#x000b1;&#x02009;6.1</td><td>28.1&#x02009;&#x000b1;&#x02009;3.9</td><td char="." align="char">0.24</td></tr><tr><td>T-score</td><td>&#x02212;2.2&#x02009;&#x000b1;&#x02009;0.7</td><td>&#x02212;1.9&#x02009;&#x000b1;&#x02009;0.9</td><td>&#x02212;2.1&#x02009;&#x000b1;&#x02009;0.7</td><td char="." align="char">0.31</td></tr><tr><td>PTH, pmol/L</td><td>5.0&#x02009;&#x000b1;&#x02009;1.6</td><td>5.7&#x02009;&#x000b1;&#x02009;2.6</td><td>4.9&#x02009;&#x000b1;&#x02009;1.7</td><td char="." align="char">0.21</td></tr><tr><td>25-OH-D, nmol/L</td><td>25.8&#x02009;&#x000b1;&#x02009;11.2</td><td>27.1&#x02009;&#x000b1;&#x02009;17.6</td><td>26.8&#x02009;&#x000b1;&#x02009;16.0</td><td char="." align="char">0.16</td></tr><tr><td>Resting heart rate, /min</td><td>75&#x02009;&#x000b1;&#x02009;6.2</td><td>74&#x02009;&#x000b1;&#x02009;7.1</td><td>76&#x02009;&#x000b1;&#x02009;4.7</td><td char="." align="char">0.38</td></tr><tr><td>Number that occasionally consume alcohol, %<sup>a</sup>
</td><td>19 (38&#x000a0;%)</td><td>16 (32&#x000a0;%)</td><td>12 (40&#x000a0;%)</td><td char="." align="char">0.43</td></tr><tr><td>Number that consume coffee, %<sup>a,</sup>
<sup>b</sup>
</td><td>31 (62&#x000a0;%)</td><td>37 (74&#x000a0;%)</td><td>23 (76&#x000a0;%)</td><td char="." align="char">0.21</td></tr><tr><td>Smokers, %<sup>a</sup>
</td><td>5 (10&#x000a0;%)</td><td>6 (12&#x000a0;%)</td><td>3 (10&#x000a0;%)</td><td char="." align="char">0.43</td></tr><tr><td>Physical activity, kcal/week<sup>c</sup>
</td><td>3075&#x02009;&#x000b1;&#x02009;1546</td><td>3150&#x02009;&#x000b1;&#x02009;1687</td><td>3190&#x02009;&#x000b1;&#x02009;1543</td><td char="." align="char">0.54</td></tr></tbody></table><table-wrap-foot><p>Values are means&#x02009;&#x000b1;&#x02009;SD</p><p>Abbreviations: <italic>RG</italic> resistance exercise group, <italic>WG</italic> walking group, <italic>CG</italic> control group, <italic>BMI</italic> body mass index, <italic>PTH</italic> parathyroid hormone, <italic>25-OH-D</italic> 25-hydroxy vitamin D</p><p>
<sup>a</sup>As assessed by baseline questionnaire (prospective participants who consumed more than the occasional alcoholic drink were ineligible for this study)</p><p>
<sup>b</sup>Minimum 1 cup of strong black coffee daily</p><p>
<sup>c</sup>From the International Physical Activity Questionnaire</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec13"><title>Bone biomarkers</title><p>Baseline and post-intervention serum BALP, CTX, and sclerostin concentrations for the RG, WG, and CG are shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. Baseline BALP concentrations ranged from 15.8 to 71.0&#x000a0;% (mean: 41.8&#x02009;&#x000b1;&#x02009;9.6), CTX levels ranged from 30.0 to 685.0&#x000a0;pg/mL (mean: 269.8&#x02009;&#x000b1;&#x02009;127.4), and sclerostin levels ranged from 7.2 to 69.4 pmol/L (mean: 24.4&#x02009;&#x000b1;&#x02009;11.5) for all participants. Post-intervention BALP concentrations did not significantly differ from baseline values, and there were no significant between-group differences in the change in the means from baseline to post-intervention (<italic>P</italic>&#x02009;=&#x02009;0.21). The RG and CG both experienced only a non-significant rise from baseline in serum sclerostin concentrations, while the WG experienced a significant increase in serum sclerostin. Repeated measures analysis revealed significant group x time interactions (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Paired sample t-tests revealed a significant change in CTX concentrations from baseline only in the RG, and repeated measures ANOVA revealed a significant main effect of the type of the physical activity (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). We compared the osteoporotic and osteopenic participants to determine if there were any differences in the CTX changes from baseline after our interventions; RG participants who had osteoporosis experienced a significant decrease in CTX concentrations post-intervention (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01), but CTX concentrations did not change in participants in the WG or CG (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05).<table-wrap id="Tab3"><label>Table 3</label><caption><p>BALP, CTX and sclerostin concentrations in the RG, WG, and CG at baseline and post-intervention</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>RG (<italic>n</italic>&#x02009;=&#x02009;50)</th><th>WG (<italic>n</italic>&#x02009;=&#x02009;50)</th><th>CG (<italic>n</italic>&#x02009;=&#x02009;50)</th></tr></thead><tbody><tr><td colspan="3">BALP</td><td/></tr><tr><td>&#x02003;Baseline [%]<sup>a</sup>
</td><td>41.7&#x02009;&#x000b1;&#x02009;12.8</td><td>41.8&#x02009;&#x000b1;&#x02009;7.6</td><td>42.2&#x02009;&#x000b1;&#x02009;10.4</td></tr><tr><td>&#x02003;Post-intervention [%]<sup>a</sup>
</td><td>41.8&#x02009;&#x000b1;&#x02009;12.0</td><td>42.1&#x02009;&#x000b1;&#x02009;8.4</td><td>42.1&#x02009;&#x000b1;&#x02009;10.2</td></tr><tr><td>&#x02003;Change [%]<sup>b</sup>
</td><td>+0.1&#x02009;&#x000b1;&#x02009;5.0</td><td>+0.9&#x02009;&#x000b1;&#x02009;2.6</td><td>&#x02212;0.14&#x02009;&#x000b1;&#x02009;0.57</td></tr><tr><td>
<italic>&#x02003;P</italic> value</td><td>0.33</td><td>0.05</td><td>0.19</td></tr><tr><td>&#x02003;ANOVA</td><td colspan="3">
<italic>P</italic>&#x02009;=&#x02009;0.21</td></tr><tr><td>&#x02003;Post hoc tests</td><td colspan="3">
<italic>P</italic>
<sub>RG &#x02212; CG</sub>&#x02009;=&#x02009;0.90; <italic>P</italic>
<sub>RG &#x02212; WG</sub>&#x02009;=&#x02009;0.47; <italic>P</italic>
<sub>WG &#x02212; CG</sub>&#x02009;=&#x02009;0.23</td></tr><tr><td colspan="3">CTX</td><td/></tr><tr><td>&#x02003;Baseline [pg/mL]</td><td>303.6&#x02009;&#x000b1;&#x02009;156.8</td><td>247.3&#x02009;&#x000b1;&#x02009;106.2</td><td>259.1&#x02009;&#x000b1;&#x02009;110.2</td></tr><tr><td>&#x02003;Post-intervention [pg/mL]</td><td>276.4&#x02009;&#x000b1;&#x02009;143.6</td><td>253.9&#x02009;&#x000b1;&#x02009;107.5</td><td>256.7&#x02009;&#x000b1;&#x02009;111.2</td></tr><tr><td>&#x02003;Change [pg/mL]<sup>b</sup>
</td><td>&#x02212;27.2&#x02009;&#x000b1;&#x02009;33.5</td><td>+6.6&#x02009;&#x000b1;&#x02009;30.7</td><td>&#x02212;2.4&#x02009;&#x000b1;&#x02009;14.6</td></tr><tr><td>
<italic>&#x02003;P</italic> value (paired t)</td><td>&#x0003c;0.01</td><td>0.11</td><td>0.37</td></tr><tr><td>&#x02003;ANOVA</td><td colspan="3">
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01</td></tr><tr><td>&#x02003;Post hoc tests</td><td colspan="3">
<italic>P</italic>
<sub>RG &#x02212; CG</sub>&#x02009;&#x0003c;&#x02009;0.01; <italic>P</italic>
<sub>RG &#x02212; WG</sub>&#x02009;&#x0003c;&#x02009;0.01; <italic>P</italic>
<sub>WG &#x02212; CG</sub>&#x02009;=&#x02009;0.20</td></tr><tr><td colspan="3">SCLEROSTIN</td><td/></tr><tr><td>&#x02003;Baseline [pmol/L]</td><td>26.8&#x02009;&#x000b1;&#x02009;14.0</td><td>23.6&#x02009;&#x000b1;&#x02009;10.0</td><td>24.0&#x02009;&#x000b1;&#x02009;8.8</td></tr><tr><td>&#x02003;Post-intervention [pmol/L]</td><td>29.8&#x02009;&#x000b1;&#x02009;15.7</td><td>29.9&#x02009;&#x000b1;&#x02009;10.8</td><td>24.2&#x02009;&#x000b1;&#x02009;8.8</td></tr><tr><td>&#x02003;Change [pmol/L]<sup>b</sup>
</td><td>+2.9&#x02009;&#x000b1;&#x02009;8.6</td><td>+6.3&#x02009;&#x000b1;&#x02009;12.1</td><td>&#x02212;0.2&#x02009;&#x000b1;&#x02009;8.7</td></tr><tr><td>
<italic>&#x02003;P</italic> value</td><td>0.08</td><td>&#x0003c;0.01</td><td>0.49</td></tr><tr><td>&#x02003;ANOVA</td><td colspan="3">
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01</td></tr><tr><td>&#x02003;Post hoc tests</td><td colspan="3">
<italic>P</italic>
<sub>TG &#x02212; CG</sub>&#x02009;=&#x02009;0.1; <italic>P</italic>
<sub>TG &#x02212; WG</sub>&#x02009;=&#x02009;0.11; <italic>P</italic>
<sub>WG &#x02212; CG</sub>&#x02009;&#x0003c;&#x02009;0.01</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic>BALP</italic> bone specific alkaline phosphatase, <italic>CTX</italic> C-terminal telopeptide of type-I collagen, <italic>RG</italic> resistance exercise group, <italic>WG</italic> walking group, <italic>CG</italic> control group</p><p>
<sup>a</sup>BALP expressed as a proportion of the total value of serum ALP</p><p>
<sup>b</sup>Difference between baseline and post-intervention data</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec14"><title>Discussion</title><sec id="Sec15"><title>Direct effect of physical activity on CTX and BALP concentrations</title><p>Elevated levels of CTX indicate increased bone resorption and excessive bone turnover [<xref ref-type="bibr" rid="CR10">10</xref>]. In our study, both resistance exercise and walking induced only a minimal change in BALP, a marker of osteogenesis; however, CTX decreased significantly in the participants who performed resistance exercise, but not in those in the WG. This difference in CTX response was statistically significant, indicating that a single session of resistance exercise reduces bone resorption while a single session of walking does not. This result differs from what would be expected based on previous reports in the literature. According to Banfi et al., exercises performed for a short time are insufficient to change the concentrations of biochemical markers of bone metabolism. In addition, markers of osteogenesis have been reported to be more sensitive than markers of bone resorption to external stresses, and although stimulation of osteoblast and/or osteoclast function is exercise-dependent the osteoblast/clast response to exercise is not immediate [<xref ref-type="bibr" rid="CR32">32</xref>]. It has been reported that BALP expression by osteoblast precursors transiently increased from baseline 30&#x000a0;min after in vitro mechanical stimulation, before returning to prestimulation levels 24&#x000a0;h later [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Significant increases in BALP concentrations have also been shown at the 30th and 50th minutes of cycling, or at the end of the cycling session [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. All changes in BALP returned to baseline within 20&#x000a0;min after exercise [<xref ref-type="bibr" rid="CR35">35</xref>]. In the present study, resistance exercise induced an immediate change in CTX and sclerostin levels, but BALP concentrations did not respond to the exercise stimulus. The correlation between bone strength and age-dependent musculoskeletal loading in women has not been fully elucidated, but exercises that increase bone density in young women seem to be ineffective in older adults [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p>Previous studies have reported the short-term effects of different physical activities, including walking [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], outdoor jogging [<xref ref-type="bibr" rid="CR39">39</xref>], aerobic exercise [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], resistance training [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>] and cycling [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], on bone turnover. Gomes-Cabello et al. summarized the effects of different training programs on bone turnover in a systematic review, and found that walking only modestly increased the loads on the skeleton above those caused by gravity; thus, this type of exercise does not effectively prevent osteoporosis in older adults. Resistance exercise/strength training acts as a powerful stimulus to improve and maintain bone mass during the ageing process. Multi-component exercise programs that include strength, aerobic, and high impact and/or weight-bearing exercise, as well as whole-body vibration alone or in combination with exercise, may help to increase, or at least prevent, the decline in bone mass that occurs with ageing, especially in postmenopausal women [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p>Previous studies have reported that serum BALP concentrations increased [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR47">47</xref>], decreased [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR48">48</xref>], or remained unchanged [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] after physical activity. The association of changes in CTX concentrations with different types of physical activity has been similarly variable [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Thus, it is clear that the response of biochemical markers of bone metabolism to exercise depends on the type and intensity of the exercise performed. Bone mass is the net product of bone formation and resorption, which are tightly regulated by the equilibrium between endogenous/exogenous factors [<xref ref-type="bibr" rid="CR50">50</xref>]. Biochemical markers of bone formation and resorption are very responsive to physical exercise, but their response varies depending on the type of exercise. Both gravitational loading and the forces generated by muscle contraction play important roles in stimulating the skeletal response to mechanical loading [<xref ref-type="bibr" rid="CR51">51</xref>].</p></sec><sec id="Sec16"><title>Physical activity and sclerostin levels</title><p>Normal sclerostin concentrations vary with age and gender. In premenopausal and postmenopausal women normal serum sclerostin concentrations are 24.6&#x02009;&#x000b1;&#x02009;5.7 pmol/L and 30.3&#x02009;&#x000b1;&#x02009;8.8 pmol/L, respectively. In this study, the mean overall sclerostin concentration before exercise was 24.8&#x02009;&#x000b1;&#x02009;11.5 pmol/L. Serum sclerostin levels increase with age in both genders, probably contributing to the age-dependent decrease in bone formation [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p>Situations associated with bone resorption are accompanied by increases in serum sclerostin concentrations. Ardawi et al. demonstrated that even a small increase in physical loading induced a significant decrease in serum sclerostin concentrations and a concomitant increase in markers of bone formation [<xref ref-type="bibr" rid="CR20">20</xref>]. Spatz et al. confirmed that the mineral content of bone significantly decreased after 90&#x000a0;days of bed rest, and this change was accompanied by a significant increase in serum sclerostin levels [<xref ref-type="bibr" rid="CR18">18</xref>]. Similarly, postmenopausal women who became immobile as a result of stroke had significantly higher serum sclerostin concentrations than controls; this was accompanied by a decreased bone stiffness index determined by quantitative ultrasound [<xref ref-type="bibr" rid="CR19">19</xref>]. Lombardi et al. studied athletes and found higher sclerostin levels in females than in males; in addition, sclerostin concentrations were higher in males participating in weight-bearing disciplines than in those who participated in non-weight-bearing sports [<xref ref-type="bibr" rid="CR50">50</xref>]. Sheng et al. studied healthy postmenopausal women and found significantly higher serum sclerostin levels in those without OP than in those with OP [<xref ref-type="bibr" rid="CR53">53</xref>]. Xu et al. found a positive correlation between serum sclerostin and lumbar spine bone mineral density and no significant association of serum sclerostin with age or body mass index in postmenopausal osteoporotic women [<xref ref-type="bibr" rid="CR54">54</xref>]. In the present study, serum sclerostin concentrations increased by 11 and 26&#x000a0;% in participants in the RG and WG, respectively. Bone tissue is mechanosensitive [<xref ref-type="bibr" rid="CR55">55</xref>]. After a mechanical stimulus, sclerostin secreted by osteocytes travels through the osteocyte canaliculi to the bone surface where it binds to the coreceptors LRP5 and LRP6 (low-density lipoprotein receptor-related protein 5 and 6) thus preventing Wnt (Wingless-type mouse mammary tumor virus integration site family member) signaling and thereby reducing osteoblastogenesis and bone formation [<xref ref-type="bibr" rid="CR56">56</xref>]. Bone resorption begins immediately after mechanical loading and at the same time, but to a lesser extent, bone formation also begins. Of the parameters that we studied, sclerostin responded the most quickly to mechanical loading. Treatments that inhibit sclerostin may be a promising targeted therapy for bone loss of various origins. Both of the types of physical activity that we studied significantly increased serum sclerostin levels. An antibody that targets sclerostin, decreasing endogenous levels of sclerostin while increasing bone mineral density, is currently in phase-III clinical trials [<xref ref-type="bibr" rid="CR17">17</xref>]. Thus, if a sclerostin-inhibiting therapy is introduced, the medication will conceivably be more effective when applied after physical exercise.</p><p>The strength of the present study was that it examined the direct effects of a single resistance exercise or walking session on sclerostin and biochemical markers of bone metabolism. Its further positive features include the homogeneity of the groups, as well as the careful assessment and exclusion of underlying diseases, medications, hormone replacement therapies, and other confounding circumstances. However, our study also had a number of limitations. It analyzed only the short-term effects of the exercises. Participants had wide age and T-score ranges, both of which have been reported to influence bone turnover [<xref ref-type="bibr" rid="CR23">23</xref>]. The intensity of the exercise was not well adapted to the participants; a higher intensity may have had more effect on BALP values. In addition, we did not measure serum osteocalcin concentrations. Although both osteocalcin and BALP are osteoblast-specific proteins that are used as markers of bone formation, they are secreted during different phases of osteoblast development [<xref ref-type="bibr" rid="CR57">57</xref>]. BALP is expressed by newly differentiated osteoblasts, whereas osteocalcin is secreted by mature osteoblasts [<xref ref-type="bibr" rid="CR57">57</xref>]; thus, it may have been useful to include measurement of osteocalcin concentrations in our analysis.</p></sec></sec><sec id="Sec17"><title>Conclusions</title><p>Our findings provide insight into the direct effects of resistance exercises and walking on biochemical markers of bone metabolism in older adults with low bone mass. Physical activity of appropriate type, duration, and intensity can influence bone turnover, causing a detectable change in serum concentrations of biochemical markers of bone metabolism and in serum sclerostin levels. The results of the study are consistent with previous reports in the literature indicating that the forces generated by muscle contraction play an important role in stimulating bone resorption, which is evident in the change in CTX concentration after exercise in the RG group. Further studies may uncover the long-term effect of resistance training on sclerostin and Wnt/&#x003b2;-catenin pathway.</p></sec><sec id="Sec18"><title>Abbreviations</title><p>25-OH-D, 25-hydroxy vitamin D; ANOVA, analysis of variance; BALP, bone-specific alkaline phosphatase; BMI, body mass index; BMU, bone multicellular unit; CG, control group; CTX, carboxy-terminal cross-linked telopeptide of type I collagen; DEXA, dual energy x-ray absorptiometry; IPAQ, international physical activity questionnaire; NTX, amino-terminal cross-linked telopeptide of type I collagen; OPG, osteoprotegerin; PTH, parathyroid hormone; RANK, receptor activator of nuclear factor &#x00138; B; RG, resistance exercise group; WG, walking group</p></sec></body><back><ack><title>Acknowledgements</title><p>This study was supported by the Faculty of Health Sciences, University of P&#x000e9;cs.</p><sec id="FPar1"><title>Authors&#x02019; contributions</title><p>The authors met all the following conditions: (1) substantial contribution to the concept and design (GGCS, VB, ES and BS), (2) acquisition of data (EP, GGCS, BM and VB), (3) analysis and interpretation of data, and drafting and revising the article (GGCS, VB, EP, BS, JB). All authors read and approved the final manuscript.</p></sec><sec id="FPar2"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Ma&#x000ef;moun L SC-</collab></person-group><article-title>Effects of physical activity on bone remodeling</article-title><source>Metab Clin Exp</source><year>2011</year><volume>60</volume><issue>3</issue><fpage>7</fpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeming</surname><given-names>DJHK</given-names></name><name><surname>Byrjalsen</surname><given-names>I</given-names></name><etal/></person-group><article-title>Is bone quality associated with collagen age?</article-title><source>Osteoporos Int</source><year>2009</year><volume>20</volume><issue>9</issue><fpage>10</fpage><pub-id pub-id-type="doi">10.1007/s00198-009-0904-3</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maimoun</surname><given-names>L</given-names></name><name><surname>Sultan</surname><given-names>C</given-names></name></person-group><article-title>Effect of physical activity on calcium homeostasis and calciotropic hormones: a review</article-title><source>Calcif Tissue Int</source><year>2009</year><volume>85</volume><issue>4</issue><fpage>277</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1007/s00223-009-9277-z</pub-id><pub-id pub-id-type="pmid">19760298</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>JS</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Galea</surname><given-names>GL</given-names></name><name><surname>Meakin</surname><given-names>LB</given-names></name><name><surname>Sunters</surname><given-names>A</given-names></name><name><surname>Lanyon</surname><given-names>LE</given-names></name></person-group><article-title>Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading</article-title><source>Curr Osteoporos Rep</source><year>2011</year><volume>9</volume><issue>2</issue><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s11914-011-0050-7</pub-id><pub-id pub-id-type="pmid">21384138</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frost</surname><given-names>HM</given-names></name></person-group><article-title>Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's law: the bone modeling problem</article-title><source>Anat Rec</source><year>1990</year><volume>226</volume><issue>4</issue><fpage>403</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/ar.1092260402</pub-id><pub-id pub-id-type="pmid">2184695</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amarasekara</surname><given-names>DS</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Rho</surname><given-names>J</given-names></name></person-group><article-title>Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases</article-title><source>J. Immunol. Res.</source><year>2015</year><volume>2015</volume><fpage>832127</fpage><pub-id pub-id-type="doi">10.1155/2015/832127</pub-id><pub-id pub-id-type="pmid">26065006</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>ML</given-names></name><name><surname>Kamel</surname><given-names>MA</given-names></name></person-group><article-title>The Wnt signaling pathway and bone metabolism</article-title><source>Curr Opin Rheumatol</source><year>2007</year><volume>19</volume><issue>4</issue><fpage>376</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1097/BOR.0b013e32816e06f9</pub-id><pub-id pub-id-type="pmid">17551370</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milat</surname><given-names>F</given-names></name><name><surname>Ng</surname><given-names>KW</given-names></name></person-group><article-title>Is Wnt signalling the final common pathway leading to bone formation?</article-title><source>Mol Cell Endocrinol</source><year>2009</year><volume>310</volume><issue>1&#x02013;2</issue><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2009.06.002</pub-id><pub-id pub-id-type="pmid">19524639</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibel</surname><given-names>MJ</given-names></name></person-group><article-title>Biochemical markers of bone turnover: part I: biochemistry and variability</article-title><source>Clin Biochem Rev./Australian Association of Clinical Biochemists</source><year>2005</year><volume>26</volume><issue>4</issue><fpage>97</fpage><lpage>122</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnero</surname><given-names>P</given-names></name><name><surname>Delmas</surname><given-names>PD</given-names></name></person-group><article-title>Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease</article-title><source>J Clin Endocrinol Metab</source><year>1993</year><volume>77</volume><issue>4</issue><fpage>1046</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">8104954</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>Seibel</surname><given-names>MJ</given-names></name><name><surname>Kraenzlin</surname><given-names>ME</given-names></name></person-group><article-title>Use of bone turnover markers in the real world: are we there yet?</article-title><source>J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.</source><year>2009</year><volume>24</volume><issue>3</issue><fpage>386</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1359/jbmr.090104</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnero</surname><given-names>P</given-names></name><name><surname>Ferreras</surname><given-names>M</given-names></name><name><surname>Karsdal</surname><given-names>MA</given-names></name><name><surname>Nicamhlaoibh</surname><given-names>R</given-names></name><name><surname>Risteli</surname><given-names>J</given-names></name><name><surname>Borel</surname><given-names>O</given-names></name><name><surname>Qvist</surname><given-names>P</given-names></name><name><surname>Delmas</surname><given-names>PD</given-names></name><name><surname>Foged</surname><given-names>NT</given-names></name><name><surname>Delaisse</surname><given-names>JM</given-names></name></person-group><article-title>The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation</article-title><source>J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.</source><year>2003</year><volume>18</volume><issue>5</issue><fpage>859</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2003.18.5.859</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnero</surname><given-names>P</given-names></name><name><surname>Gineyts</surname><given-names>E</given-names></name><name><surname>Riou</surname><given-names>JP</given-names></name><name><surname>Delmas</surname><given-names>PD</given-names></name></person-group><article-title>Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease</article-title><source>J Clin Endocrinol Metab</source><year>1994</year><volume>79</volume><issue>3</issue><fpage>780</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8077361</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christgau</surname><given-names>S</given-names></name><name><surname>Rosenquist</surname><given-names>C</given-names></name><name><surname>Alexandersen</surname><given-names>P</given-names></name><name><surname>Bjarnason</surname><given-names>NH</given-names></name><name><surname>Ravn</surname><given-names>P</given-names></name><name><surname>Fledelius</surname><given-names>C</given-names></name><name><surname>Herling</surname><given-names>C</given-names></name><name><surname>Qvist</surname><given-names>P</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name></person-group><article-title>Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides</article-title><source>Clin Chem</source><year>1998</year><volume>44</volume><issue>11</issue><fpage>2290</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">9799756</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avbersek-Luznik</surname><given-names>I</given-names></name><name><surname>Gmeiner Stopar</surname><given-names>T</given-names></name><name><surname>Marc</surname><given-names>J</given-names></name></person-group><article-title>Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation</article-title><source>Clin Chem Lab Med</source><year>2007</year><volume>45</volume><issue>8</issue><fpage>1014</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1515/CCLM.2007.186</pub-id><pub-id pub-id-type="pmid">17579570</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moester</surname><given-names>MJ</given-names></name><name><surname>Papapoulos</surname><given-names>SE</given-names></name><name><surname>Lowik</surname><given-names>CW</given-names></name><name><surname>van Bezooijen</surname><given-names>RL</given-names></name></person-group><article-title>Sclerostin: current knowledge and future perspectives</article-title><source>Calcif Tissue Int</source><year>2010</year><volume>87</volume><issue>2</issue><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1007/s00223-010-9372-1</pub-id><pub-id pub-id-type="pmid">20473488</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compton</surname><given-names>JT</given-names></name><name><surname>Lee</surname><given-names>FY</given-names></name></person-group><article-title>A review of osteocyte function and the emerging importance of sclerostin</article-title><source>J Bone Joint Surg Am</source><year>2014</year><volume>96</volume><issue>19</issue><fpage>1659</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.2106/JBJS.M.01096</pub-id><pub-id pub-id-type="pmid">25274791</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spatz</surname><given-names>JM</given-names></name><name><surname>Fields</surname><given-names>EE</given-names></name><name><surname>Yu</surname><given-names>EW</given-names></name><name><surname>Divieti Pajevic</surname><given-names>P</given-names></name><name><surname>Bouxsein</surname><given-names>ML</given-names></name><name><surname>Sibonga</surname><given-names>JD</given-names></name><name><surname>Zwart</surname><given-names>SR</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Serum sclerostin increases in healthy adult men during bed rest</article-title><source>J Clin Endocrinol Metab</source><year>2012</year><volume>97</volume><issue>9</issue><fpage>E1736</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-1579</pub-id><pub-id pub-id-type="pmid">22767636</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudio</surname><given-names>A</given-names></name><name><surname>Pennisi</surname><given-names>P</given-names></name><name><surname>Bratengeier</surname><given-names>C</given-names></name><name><surname>Torrisi</surname><given-names>V</given-names></name><name><surname>Lindner</surname><given-names>B</given-names></name><name><surname>Mangiafico</surname><given-names>RA</given-names></name><name><surname>Pulvirenti</surname><given-names>I</given-names></name><name><surname>Hawa</surname><given-names>G</given-names></name><name><surname>Tringali</surname><given-names>G</given-names></name><name><surname>Fiore</surname><given-names>CE</given-names></name></person-group><article-title>Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><issue>5</issue><fpage>2248</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1210/jc.2010-0067</pub-id><pub-id pub-id-type="pmid">20305005</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardawi</surname><given-names>MS</given-names></name><name><surname>Rouzi</surname><given-names>AA</given-names></name><name><surname>Qari</surname><given-names>MH</given-names></name></person-group><article-title>Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study</article-title><source>J Clin Endocrinol Metab</source><year>2012</year><volume>97</volume><issue>10</issue><fpage>3691</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1210/jc.2011-3361</pub-id><pub-id pub-id-type="pmid">22865898</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>I</given-names></name><name><surname>Parini</surname><given-names>P</given-names></name><name><surname>Gustafsson</surname><given-names>SA</given-names></name><name><surname>Andersson</surname><given-names>G</given-names></name><name><surname>Brinck</surname><given-names>J</given-names></name></person-group><article-title>Physical training increases osteoprotegerin in postmenopausal women</article-title><source>J Bone Miner Metab</source><year>2012</year><volume>30</volume><issue>2</issue><fpage>202</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00774-011-0304-6</pub-id><pub-id pub-id-type="pmid">21823052</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Panel on Prevention of Falls in Older Persons AGS, British Geriatrics S</collab></person-group><article-title>Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons</article-title><source>J Am Geriatr Soc</source><year>2011</year><volume>59</volume><issue>1</issue><fpage>148</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.03234.x</pub-id><pub-id pub-id-type="pmid">21226685</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanis</surname><given-names>JA</given-names></name><name><surname>Burlet</surname><given-names>N</given-names></name><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Delmas</surname><given-names>PD</given-names></name><name><surname>Reginster</surname><given-names>JY</given-names></name><name><surname>Borgstrom</surname><given-names>F</given-names></name><name><surname>Rizzoli</surname><given-names>R</given-names></name><collab>European Society for C, Economic Aspects of O, Osteoarthritis</collab></person-group><article-title>European guidance for the diagnosis and management of osteoporosis in postmenopausal women</article-title><source>Osteoporos. Int.</source><year>2008</year><volume>19</volume><issue>4</issue><fpage>399</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1007/s00198-008-0560-z</pub-id><pub-id pub-id-type="pmid">18266020</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American College of Sports M</collab><name><surname>Chodzko-Zajko</surname><given-names>WJ</given-names></name><name><surname>Proctor</surname><given-names>DN</given-names></name><name><surname>Fiatarone Singh</surname><given-names>MA</given-names></name><name><surname>Minson</surname><given-names>CT</given-names></name><name><surname>Nigg</surname><given-names>CR</given-names></name><name><surname>Salem</surname><given-names>GJ</given-names></name><name><surname>Skinner</surname><given-names>JS</given-names></name></person-group><article-title>American College of Sports Medicine position stand. Exercise and physical activity for older adults</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><issue>7</issue><fpage>1510</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181a0c95c</pub-id><pub-id pub-id-type="pmid">19516148</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guadalupe-Grau</surname><given-names>A</given-names></name><name><surname>Fuentes</surname><given-names>T</given-names></name><name><surname>Guerra</surname><given-names>B</given-names></name><name><surname>Calbet</surname><given-names>JA</given-names></name></person-group><article-title>Exercise and bone mass in adults</article-title><source>Sports Med</source><year>2009</year><volume>39</volume><issue>6</issue><fpage>439</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.2165/00007256-200939060-00002</pub-id><pub-id pub-id-type="pmid">19453205</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Layne</surname><given-names>JE</given-names></name><name><surname>Nelson</surname><given-names>ME</given-names></name></person-group><article-title>The effects of progressive resistance training on bone density: a review</article-title><source>Med Sci Sports Exerc</source><year>1999</year><volume>31</volume><issue>1</issue><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1097/00005768-199901000-00006</pub-id><pub-id pub-id-type="pmid">9927006</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maimoun</surname><given-names>L</given-names></name><name><surname>Manetta</surname><given-names>J</given-names></name><name><surname>Couret</surname><given-names>I</given-names></name><name><surname>Dupuy</surname><given-names>AM</given-names></name><name><surname>Mariano-Goulart</surname><given-names>D</given-names></name><name><surname>Micallef</surname><given-names>JP</given-names></name><name><surname>Peruchon</surname><given-names>E</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name></person-group><article-title>The intensity level of physical exercise and the bone metabolism response</article-title><source>Int J Sports Med</source><year>2006</year><volume>27</volume><issue>2</issue><fpage>105</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1055/s-2005-837621</pub-id><pub-id pub-id-type="pmid">16475055</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>JD</given-names></name><name><surname>Cuneo</surname><given-names>RC</given-names></name><name><surname>Lundberg</surname><given-names>PA</given-names></name><name><surname>Rosen</surname><given-names>T</given-names></name><name><surname>Jorgensen</surname><given-names>JO</given-names></name><name><surname>Longobardi</surname><given-names>S</given-names></name><name><surname>Keay</surname><given-names>N</given-names></name><name><surname>Sacca</surname><given-names>L</given-names></name><name><surname>Christiansen</surname><given-names>JS</given-names></name><name><surname>Bengtsson</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males</article-title><source>J Clin Endocrinol Metab</source><year>2000</year><volume>85</volume><issue>1</issue><fpage>124</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10634375</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qvist</surname><given-names>P</given-names></name><name><surname>Christgau</surname><given-names>S</given-names></name><name><surname>Pedersen</surname><given-names>BJ</given-names></name><name><surname>Schlemmer</surname><given-names>A</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name></person-group><article-title>Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting</article-title><source>Bone</source><year>2002</year><volume>31</volume><issue>1</issue><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S8756-3282(02)00791-3</pub-id><pub-id pub-id-type="pmid">12110413</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmann</surname><given-names>P</given-names></name><name><surname>Body</surname><given-names>JJ</given-names></name><name><surname>Boonen</surname><given-names>S</given-names></name><name><surname>Boutsen</surname><given-names>Y</given-names></name><name><surname>Devogelaer</surname><given-names>JP</given-names></name><name><surname>Goemaere</surname><given-names>S</given-names></name><name><surname>Kaufman</surname><given-names>JM</given-names></name><name><surname>Reginster</surname><given-names>JY</given-names></name><name><surname>Gangji</surname><given-names>V</given-names></name><collab>Members of Advisory Board on Bone M</collab></person-group><article-title>Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club</article-title><source>Int J Clin Pract</source><year>2009</year><volume>63</volume><issue>1</issue><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2008.01911.x</pub-id><pub-id pub-id-type="pmid">19125989</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>CL</given-names></name><name><surname>Marshall</surname><given-names>AL</given-names></name><name><surname>Sjostrom</surname><given-names>M</given-names></name><name><surname>Bauman</surname><given-names>AE</given-names></name><name><surname>Booth</surname><given-names>ML</given-names></name><name><surname>Ainsworth</surname><given-names>BE</given-names></name><name><surname>Pratt</surname><given-names>M</given-names></name><name><surname>Ekelund</surname><given-names>U</given-names></name><name><surname>Yngve</surname><given-names>A</given-names></name><name><surname>Sallis</surname><given-names>JF</given-names></name><etal/></person-group><article-title>International physical activity questionnaire: 12-country reliability and validity</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><issue>8</issue><fpage>1381</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000078924.61453.FB</pub-id><pub-id pub-id-type="pmid">12900694</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banfi</surname><given-names>G</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colombini</surname><given-names>A</given-names></name><name><surname>Lippi</surname><given-names>G</given-names></name></person-group><article-title>Bone metabolism markers in sports medicine</article-title><source>Sports Med</source><year>2010</year><volume>40</volume><issue>8</issue><fpage>697</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.2165/11533090-000000000-00000</pub-id><pub-id pub-id-type="pmid">20632739</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>MC</given-names></name><name><surname>Zou</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>LC</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name></person-group><article-title>Expression of bone-related genes in bone marrow MSCs after cyclic mechanical strain: implications for distraction osteogenesis</article-title><source>Int J Oral Sci</source><year>2009</year><volume>1</volume><issue>3</issue><fpage>143</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.4248/IJOS.09021</pub-id><pub-id pub-id-type="pmid">20695079</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>MC</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>HQ</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name><name><surname>Han</surname><given-names>LC</given-names></name></person-group><article-title>Mechanical strain induces osteogenic differentiation: Cbfa1 and Ets-1 expression in stretched rat mesenchymal stem cells</article-title><source>Int J Oral Maxillofac Surg</source><year>2008</year><volume>37</volume><issue>5</issue><fpage>453</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ijom.2007.12.008</pub-id><pub-id pub-id-type="pmid">18272346</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudberg</surname><given-names>A</given-names></name><name><surname>Magnusson</surname><given-names>P</given-names></name><name><surname>Larsson</surname><given-names>L</given-names></name><name><surname>Joborn</surname><given-names>H</given-names></name></person-group><article-title>Serum isoforms of bone alkaline phosphatase increase during physical exercise in women</article-title><source>Calcif Tissue Int</source><year>2000</year><volume>66</volume><issue>5</issue><fpage>342</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s002230010071</pub-id><pub-id pub-id-type="pmid">10773103</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittweger</surname><given-names>J</given-names></name></person-group><article-title>Ten years muscle-bone hypothesis: what have we learned so far?--almost a festschrift</article-title><source>J Musculoskelet Neuronal Interact</source><year>2008</year><volume>8</volume><issue>2</issue><fpage>174</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18622086</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maimoun</surname><given-names>L</given-names></name><name><surname>Simar</surname><given-names>D</given-names></name><name><surname>Caillaud</surname><given-names>C</given-names></name><name><surname>Coste</surname><given-names>O</given-names></name><name><surname>Barbotte</surname><given-names>E</given-names></name><name><surname>Peruchon</surname><given-names>E</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Mariano-Goulart</surname><given-names>D</given-names></name></person-group><article-title>Response of calciotropic hormones and bone turnover to brisk walking according to age and fitness level</article-title><source>J. Sci. Med. Sport Aust</source><year>2009</year><volume>12</volume><issue>4</issue><fpage>463</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jsams.2008.05.004</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>L</given-names></name><name><surname>Rutherford</surname><given-names>OM</given-names></name><name><surname>James</surname><given-names>I</given-names></name><name><surname>Crowley</surname><given-names>C</given-names></name><name><surname>Comer</surname><given-names>M</given-names></name><name><surname>Wolman</surname><given-names>R</given-names></name></person-group><article-title>The acute effects of exercise on bone turnover</article-title><source>Int J Sports Med</source><year>1997</year><volume>18</volume><issue>4</issue><fpage>247</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1055/s-2007-972628</pub-id><pub-id pub-id-type="pmid">9231839</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorsen</surname><given-names>K</given-names></name><name><surname>Kristoffersson</surname><given-names>A</given-names></name><name><surname>Hultdin</surname><given-names>J</given-names></name><name><surname>Lorentzon</surname><given-names>R</given-names></name></person-group><article-title>Effects of moderate endurance exercise on calcium, parathyroid hormone, and markers of bone metabolism in young women</article-title><source>Calcif Tissue Int</source><year>1997</year><volume>60</volume><issue>1</issue><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s002239900179</pub-id><pub-id pub-id-type="pmid">9030474</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosun</surname><given-names>A</given-names></name><name><surname>Bolukbasi</surname><given-names>N</given-names></name><name><surname>Cingi</surname><given-names>E</given-names></name><name><surname>Beyazova</surname><given-names>M</given-names></name><name><surname>Unlu</surname><given-names>M</given-names></name></person-group><article-title>Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women</article-title><source>Mod Rheumatol/the Japan Rheumatism Association</source><year>2006</year><volume>16</volume><issue>5</issue><fpage>300</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.3109/s10165-006-0503-5</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zittermann</surname><given-names>A</given-names></name><name><surname>Sabatschus</surname><given-names>O</given-names></name><name><surname>Jantzen</surname><given-names>S</given-names></name><name><surname>Platen</surname><given-names>P</given-names></name><name><surname>Danz</surname><given-names>A</given-names></name><name><surname>Stehle</surname><given-names>P</given-names></name></person-group><article-title>Evidence for an acute rise of intestinal calcium absorption in response to aerobic exercise</article-title><source>Eur J Nutr</source><year>2002</year><volume>41</volume><issue>5</issue><fpage>189</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/s00394-002-0375-1</pub-id><pub-id pub-id-type="pmid">12395212</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashizawa</surname><given-names>N</given-names></name><name><surname>Ouchi</surname><given-names>G</given-names></name><name><surname>Fujimura</surname><given-names>R</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Tokuyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name></person-group><article-title>Effects of a single bout of resistance exercise on calcium and bone metabolism in untrained young males</article-title><source>Calcif Tissue Int</source><year>1998</year><volume>62</volume><issue>2</issue><fpage>104</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s002239900402</pub-id><pub-id pub-id-type="pmid">9437042</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whipple</surname><given-names>TJ</given-names></name><name><surname>Le</surname><given-names>BH</given-names></name><name><surname>Demers</surname><given-names>LM</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name><name><surname>Petit</surname><given-names>MA</given-names></name><name><surname>Sharkey</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>NI</given-names></name></person-group><article-title>Acute effects of moderate intensity resistance exercise on bone cell activity</article-title><source>Int J Sports Med</source><year>2004</year><volume>25</volume><issue>7</issue><fpage>496</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1055/s-2004-820942</pub-id><pub-id pub-id-type="pmid">15459829</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristoffersson</surname><given-names>A</given-names></name><name><surname>Hultdin</surname><given-names>J</given-names></name><name><surname>Holmlund</surname><given-names>I</given-names></name><name><surname>Thorsen</surname><given-names>K</given-names></name><name><surname>Lorentzon</surname><given-names>R</given-names></name></person-group><article-title>Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism</article-title><source>Int J Sports Med</source><year>1995</year><volume>16</volume><issue>3</issue><fpage>145</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1055/s-2007-972982</pub-id><pub-id pub-id-type="pmid">7649703</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillaume</surname><given-names>G</given-names></name><name><surname>Chappard</surname><given-names>D</given-names></name><name><surname>Audran</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of the bone status in high-level cyclists</article-title><source>J Clin Densitom</source><year>2012</year><volume>15</volume><issue>1</issue><fpage>103</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jocd.2011.08.001</pub-id><pub-id pub-id-type="pmid">22071023</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Cabello</surname><given-names>A</given-names></name><name><surname>Ara</surname><given-names>I</given-names></name><name><surname>Gonzalez-Aguero</surname><given-names>A</given-names></name><name><surname>Casajus</surname><given-names>JA</given-names></name><name><surname>Vicente-Rodriguez</surname><given-names>G</given-names></name></person-group><article-title>Effects of training on bone mass in older adults: a systematic review</article-title><source>Sports Med</source><year>2012</year><volume>42</volume><issue>4</issue><fpage>301</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.2165/11597670-000000000-00000</pub-id><pub-id pub-id-type="pmid">22376192</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brahm</surname><given-names>H</given-names></name><name><surname>Piehl-Aulin</surname><given-names>K</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name><name><surname>Ljunghall</surname><given-names>S</given-names></name></person-group><article-title>Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise</article-title><source>Calcif Tissue Int</source><year>1997</year><volume>60</volume><issue>2</issue><fpage>175</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1007/s002239900210</pub-id><pub-id pub-id-type="pmid">9056167</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malm</surname><given-names>HT</given-names></name><name><surname>Ronni-Sivula</surname><given-names>HM</given-names></name><name><surname>Viinikka</surname><given-names>LU</given-names></name><name><surname>Ylikorkala</surname><given-names>OR</given-names></name></person-group><article-title>Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels</article-title><source>Calcif Tissue Int</source><year>1993</year><volume>52</volume><issue>3</issue><fpage>209</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/BF00298720</pub-id><pub-id pub-id-type="pmid">8481834</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillemant</surname><given-names>J</given-names></name><name><surname>Accarie</surname><given-names>C</given-names></name><name><surname>Peres</surname><given-names>G</given-names></name><name><surname>Guillemant</surname><given-names>S</given-names></name></person-group><article-title>Acute effects of an oral calcium load on markers of bone metabolism during endurance cycling exercise in male athletes</article-title><source>Calcif Tissue Int</source><year>2004</year><volume>74</volume><issue>5</issue><fpage>407</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s00223-003-0070-0</pub-id><pub-id pub-id-type="pmid">14735261</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Lanteri</surname><given-names>P</given-names></name><name><surname>Colombini</surname><given-names>A</given-names></name><name><surname>Mariotti</surname><given-names>M</given-names></name><name><surname>Banfi</surname><given-names>G</given-names></name></person-group><article-title>Sclerostin concentrations in athletes: role of load and gender</article-title><source>J Biol Regul Homeost Agents</source><year>2012</year><volume>26</volume><issue>1</issue><fpage>157</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22475109</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohrt</surname><given-names>WM</given-names></name><name><surname>Barry</surname><given-names>DW</given-names></name><name><surname>Schwartz</surname><given-names>RS</given-names></name></person-group><article-title>Muscle forces or gravity: what predominates mechanical loading on bone?</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><issue>11</issue><fpage>2050</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181a8c717</pub-id><pub-id pub-id-type="pmid">19812511</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modder</surname><given-names>UI</given-names></name><name><surname>Hoey</surname><given-names>KA</given-names></name><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>McCready</surname><given-names>LK</given-names></name><name><surname>Achenbach</surname><given-names>SJ</given-names></name><name><surname>Riggs</surname><given-names>BL</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names><suffix>3rd</suffix></name><name><surname>Khosla</surname><given-names>S</given-names></name></person-group><article-title>Relation of age, gender, and bone mass to circulating sclerostin levels in women and men</article-title><source>J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.</source><year>2011</year><volume>26</volume><issue>2</issue><fpage>373</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/jbmr.217</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>Z</given-names></name><name><surname>Tong</surname><given-names>D</given-names></name><name><surname>Ou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>E</given-names></name></person-group><article-title>Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women</article-title><source>Clin Endocrinol</source><year>2012</year><volume>76</volume><issue>6</issue><fpage>797</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2011.04315.x</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>XJ</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>YP</given-names></name><name><surname>Lu</surname><given-names>FR</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Shuai</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>CG</given-names></name><name><surname>Wu</surname><given-names>MX</given-names></name></person-group><article-title>Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis</article-title><source>Chin Med J</source><year>2013</year><volume>126</volume><issue>13</issue><fpage>2480</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23823821</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>CH</given-names></name><name><surname>Robling</surname><given-names>AG</given-names></name><name><surname>Duncan</surname><given-names>RL</given-names></name><name><surname>Burr</surname><given-names>DB</given-names></name></person-group><article-title>Do bone cells behave like a neuronal network?</article-title><source>Calcif Tissue Int</source><year>2002</year><volume>70</volume><issue>6</issue><fpage>435</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00223-001-1024-z</pub-id><pub-id pub-id-type="pmid">12149636</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>SL</given-names></name></person-group><article-title>Sclerostin</article-title><source>J Osteoporos</source><year>2010</year><volume>2010</volume><fpage>941419</fpage><pub-id pub-id-type="doi">10.4061/2010/941419</pub-id><pub-id pub-id-type="pmid">20981340</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aubin</surname><given-names>JE</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Malaval</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>AK</given-names></name></person-group><article-title>Osteoblast and chondroblast differentiation</article-title><source>Bone</source><year>1995</year><volume>17</volume><issue>2 Suppl</issue><fpage>77S</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/8756-3282(95)00183-E</pub-id><pub-id pub-id-type="pmid">8579903</pub-id></element-citation></ref></ref-list></back></article>